Benjamin Walter, MD
Medical Director, Deep Brain Stimulation Program, UH Cleveland Medical Center
Associate Professor, Neurology, CWRU School of Medicine
Director, Parkinson’s and Movement Disorder Center, University Hospitals
Neurologist Benjamin Walter, MD, is Director of the Parkinson’s & Movement Disorders Center and Medical Director of the Deep Brain Stimulation (DBS) program at University Hospitals Cleveland Medical Center. In addition, he holds the Penni and Stephen Weinberg Chair in Brain Health and is an Associate Professor of Neurology and Biomedical Engineering at Case Western Reserve University School of Medicine.
Dr. Walter is board-certified in neurology. His special interests include DBS, dystonia, functional magnetic resonance imaging (MRI), intrathecal baclofen, the mechanism of effect of DBS, movement disorders, Parkinson’s disease and tremors. Dr. Walter joined UH Cleveland Medical Center in 2008 after four years at Cleveland Clinic, where he directed the movement disorders fellowship program.
Dr. Walter completed his bachelor’s degree in biology, summa cum laude, at Emory University in Atlanta, and earned his medical degree from MCP-Hahnemann School of Medicine in Philadelphia. He completed his internship in internal medicine and residency in neurology at Emory University Hospital, as well as fellowship training in movement disorders with an emphasis on intraoperative mapping and deep brain stimulation.
In his research laboratory, Dr. Walter uses functional MRI to study mechanisms underlying changes in Parkinson’s disease and dystonia, participating in several projects funded by the National Institutes of Health (NIH). He is currently an investigator on an NIH-funded project exploring intracortical control of arm and hand function restored by functional electrical stimulation in people with spinal cord injury. He has also served as an investigator on the Enhanced Exercise Study for Patients with Parkinson’s Disease (EXCEED) study of how exercise and education affects people with Parkinson’s disease and depression, as well as on an NIH-funded project to develop an “intelligent” bicycle for rehabilitation in Parkinson’s patients.
Dr. Walter is the author of more than 20 articles in peer-reviewed medical journals, as well as five book chapters. He has presented posters and abstracts at more than 20 international and national peer-reviewed medical conferences. In addition, Dr. Walter has served as an invited lecturer/instructor at national and international medical education conferences and colloquia. He is grant reviewer for the NIH and the American Association for the Advancement of Science and also reviews manuscripts for several prominent medical journals. He is a member of the Organization for Human Brain Mapping, Society for Neuroscience, American Academy of Neurology and the Movement Disorder Society.
UH Cleveland Medical Center
Department of Neurology
11100 Euclid Ave
UH Neurological Institute
950 Clague Rd
UH Westlake Health Center, Bldg B, Ste 101
UH Medina Health Center
4001 Carrick Dr
University Suburban Health Center
1611 S Green Rd
Mechanisms of Effect of DBS, Dystonia, Tremors, Intrathecal Baclofen, Movement Disorders, Deep Brain Stimulation, Parkinson's Disease, Functional Magnetic Resonance Imaging (MRI)
American Board of Psychiatry and Neurology - Neurology
Education & Training
1995, Emory University
Medical / Professional School(s):
1999, Drexel University College of Medicine/Hahnemann University
2000, Internal Medicine - Emory University Hospital
2003, Neurology - Emory University Hospital
2004, Movement Disorders - Emory University Hospital
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Benjamin Walter, MD disclosed the following Outside Relationships with Industry:
Boehringer Ingelheim Pharmaceutical, Inc. (BIPI) - Consulting
Teva Neuroscience, Inc. - Consulting
Teva Neuroscience, Inc. - Honoraria
UCB, Inc. - Honoraria
US World Meds - Honoraria